Shopping Cart
- Remove All
- Your shopping cart is currently empty
VBY-825 is a reversible inhibitor of cathepsin with high potency against cathepsins B, L, S and V.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $278 | In Stock | |
2 mg | $413 | In Stock | |
5 mg | $689 | In Stock | |
10 mg | $979 | In Stock | |
25 mg | $1,460 | In Stock | |
50 mg | $1,960 | In Stock | |
100 mg | $2,650 | In Stock |
Description | VBY-825 is a reversible inhibitor of cathepsin with high potency against cathepsins B, L, S and V. |
In vitro | VBY-825 is a potent assayed cathepsins inhibitor and its potency against at least one cathepsin, cathepsin S, extends across species relevant for pharmacology studies, specifically mouse. 10 mg/kg/day dose of VBY-825 achieves a trough plasma concentration >200nM, which is well above that required for full inhibition of the intracellular activity of cathepsins B, F, K, L, S and V in both mouse and human cell lines. |
Molecular Weight | 535.55 |
Formula | C23H29F4N3O5S |
Cas No. | 1310340-58-9 |
Smiles | [C@@H](N[C@H](C(N[C@H](C(C(NC1CC1)=O)=O)CC)=O)CS(CC2CC2)(=O)=O)([C@](F)(F)F)C3=CC=C(F)C=C3 |
Relative Density. | 1.39 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 125 mg/mL (233.40 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.